Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.776 | 0.240 | 4 | 94641726 | intron variant | C/T | snv | 0.30 |
|
Neoplasms; Male Urogenital Diseases | 0.700 | 1.000 | 2 | 2009 | 2018 | |||||||
|
4 | 94534108 | intron variant | C/T | snv | 0.24 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
0.851 | 0.240 | 4 | 94593458 | intron variant | A/C | snv | 0.54 |
|
Neoplasms; Stomatognathic Diseases; Otorhinolaryngologic Diseases | 0.700 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.851 | 0.240 | 4 | 94593458 | intron variant | A/C | snv | 0.54 |
|
Neoplasms; Male Urogenital Diseases | 0.700 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.851 | 0.240 | 4 | 94593458 | intron variant | A/C | snv | 0.54 |
|
Neoplasms; Male Urogenital Diseases | 0.700 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.776 | 0.240 | 4 | 94641726 | intron variant | C/T | snv | 0.30 |
|
Neoplasms; Male Urogenital Diseases | 0.700 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.776 | 0.240 | 4 | 94641726 | intron variant | C/T | snv | 0.30 |
|
Neoplasms; Stomatognathic Diseases; Otorhinolaryngologic Diseases | 0.700 | 1.000 | 1 | 2010 | 2010 | |||||||
|
1.000 | 0.120 | 4 | 94573377 | missense variant | C/T | snv | 1.0E-04 | 1.3E-04 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
|
0.925 | 0.080 | 4 | 94575731 | missense variant | C/T | snv | 0.27 | 0.25 |
|
Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2018 | 2018 | ||||||
|
1.000 | 4 | 94580015 | intron variant | T/C | snv | 0.25 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | |||||||||
|
1.000 | 4 | 94580015 | intron variant | T/C | snv | 0.25 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.925 | 0.040 | 4 | 94458590 | intron variant | A/G | snv | 0.37 |
|
Mental Disorders | 0.020 | 1.000 | 2 | 2006 | 2008 | |||||||
|
0.925 | 0.040 | 4 | 94585691 | synonymous variant | G/A | snv | 0.18 | 0.22 |
|
Mental Disorders | 0.010 | < 0.001 | 1 | 2013 | 2013 | ||||||
|
0.925 | 0.040 | 4 | 94585691 | synonymous variant | G/A | snv | 0.18 | 0.22 |
|
Mental Disorders | 0.010 | < 0.001 | 1 | 2013 | 2013 | ||||||
|
1.000 | 0.080 | 4 | 94658554 | intron variant | T/C | snv | 0.24 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.080 | 4 | 94658554 | intron variant | T/C | snv | 0.24 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.851 | 0.240 | 4 | 94593458 | intron variant | A/C | snv | 0.54 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.851 | 0.240 | 4 | 94593458 | intron variant | A/C | snv | 0.54 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.080 | 4 | 94579531 | missense variant | T/C | snv | 1.4E-05 |
|
Nervous System Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.882 | 0.080 | 4 | 94654530 | missense variant | A/G | snv | 4.0E-06 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||||
|
0.882 | 0.080 | 4 | 94654530 | missense variant | A/G | snv | 4.0E-06 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||||
|
0.882 | 0.080 | 4 | 94654530 | missense variant | A/G | snv | 4.0E-06 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||||
|
0.882 | 0.080 | 4 | 94654530 | missense variant | A/G | snv | 4.0E-06 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||||
|
0.882 | 0.080 | 4 | 94654530 | missense variant | A/G | snv | 4.0E-06 |
|
0.010 | 1.000 | 1 | 2008 | 2008 | ||||||||
|
0.776 | 0.240 | 4 | 94641726 | intron variant | C/T | snv | 0.30 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 |